𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9127 POSTER Phase II Study of Eriotinib Plus Gemcitabine in First Line Treatment of Poor Prognosis (ECOG PS 2) Advanced Non-small Cell Lung Cancer Patients

✍ Scribed by Grigorescu, A.

Book ID
122491825
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
40 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, Phase II stud
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma
✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun